Development of therapy killing or activating targeted cells using bio-techniques
Project/Area Number |
19360378
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Biofunction/Bioprocess
|
Research Institution | Chubu University |
Principal Investigator |
KOBAYASHI Takeshi Chubu University, 応用生物学部, 教授 (10043324)
|
Project Period (FY) |
2007 – 2009
|
Project Status |
Completed (Fiscal Year 2009)
|
Budget Amount *help |
¥18,200,000 (Direct Cost: ¥14,000,000、Indirect Cost: ¥4,200,000)
Fiscal Year 2009: ¥5,200,000 (Direct Cost: ¥4,000,000、Indirect Cost: ¥1,200,000)
Fiscal Year 2008: ¥5,850,000 (Direct Cost: ¥4,500,000、Indirect Cost: ¥1,350,000)
Fiscal Year 2007: ¥7,150,000 (Direct Cost: ¥5,500,000、Indirect Cost: ¥1,650,000)
|
Keywords | がん / バイオテクノロジー / マグネタイト微粒子 / 温熱療法 / 加温 / リポソーム / 癌 / 生物・生体工学 / 熱死滅の促進 |
Research Abstract |
I have developed a new cancer hyperthermia using magnetic nanoparticles. Combination therapy with injection of imiquimod well known as immuno-inducer and hyperthermia was synergistic. Translational research was started at Shinshu University from Oct.30, 2008, at Nagoya University from Nov.11, 2009, and Tobata Kyouritu Hospital from Feb.8, 2010.
|
Report
(4 results)
Research Products
(43 results)